الفهرس 
Type 2 diabetes mellitusOnly 14 pages are availabe for public view
 |  | from | 16 |  |  |
| | | from | 16 | | |
Abstract
The aim of this study was to re-evaluate early vitrectomy for treatment of diabetic vitreous haemorrliage in type 2 diabetes Forty-five patients were operated upon by pars plana vitrectomy for diabetic vitreous haemorrhage in 10.53 1.89 . weeks after the onset of haemorrhage. All patients had intraoperative endolaser by argon green laser in five patients and diode laser in 40 patients. Ninety one patients had improvement of their visual acuity compared with the preoperative visual acuity. There was no significant difference between the postoperative best corrected visual acuity and the best preoperative best corrected visual acuity recorded in the year preceding the onset of vitreous hae morrhage. Compared with the results of DRVS (1985), the study results were significantly better than the early vitrectomy group of the DFWS, and clinically better but statistically insignificant than the deferral group. The incidence of postoperative retinal detachment was almost similar to the incidence in the deferral group of the DRVS and slightly less than in the early vitrectomy group, yet statistically insignificant. The incidence of postoperative vitreous haemorrhage was less than the reported incidence in the literature and this was mostly secondary to the early vitrectomy and the routine application of intraoperative endolaser. Only one patient had phthisis bulbi following retinal detachment twice postoperatively. This patient was the only pati snt to have NPL vision postoperatively. In conclusion, early vitrectomy with endolaser treatment proved to be a safe and reliable option for treatment of diabetic vitreous haemorrhage in type 2 diabetes mellitus. However, the study size was small and unicentered considering the magnitude of the problem and dramatic complications of the procedure. The researchers recominend the design of multicentre randomized controlled study to reevaluate the role of early vitrectomy for diabetic vitreous haemorrhage in type 2 diabetes mellitus.